Cancer nanomedicine: from targeted delivery to combination therapy
about
The TWEAK receptor Fn14 is a potential cell surface portal for targeted delivery of glioblastoma therapeuticsNANOMEDICINE: will it offer possibilities to overcome multiple drug resistance in cancer?The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug deliveryMechanisms of action of therapeutic antibodies for cancerCyanine based Nanoprobes for Cancer Theranostics.Controlled Drug Release and Chemotherapy Response in a Novel Acoustofluidic 3D Tumor Platform.Nanotechnology in the war against cancer: new arms against an old enemy - a clinical view.Novel multifunctional pH-sensitive nanoparticles loaded into microbubbles as drug delivery vehicles for enhanced tumor targetingBiomimetic carriers mimicking leukocyte plasma membrane to increase tumor vasculature permeability.Hyaluronic acid-functionalized polymeric nanoparticles for colon cancer-targeted combination chemotherapy.Enhanced Blood Suspensibility and Laser-Activated Tumor-specific Drug Release of Theranostic Mesoporous Silica Nanoparticles by Functionalizing with Erythrocyte Membranes.Nanomedicines for Endothelial Disorders.α-Tocopheryl succinate-based amphiphilic block copolymers obtained by RAFT and their nanoparticles for the treatment of cancerThe identification of goat peroxiredoxin-5 and the evaluation and enhancement of its stability by nanoparticle formation.In vivo biodistribution, biocompatibility, and efficacy of sorafenib-loaded lipid-based nanosuspensions evaluated experimentally in cancerTf-PEG-PLL-PLGA nanoparticles enhanced chemosensitivity for hypoxia-responsive tumor cells.Polydopamine Coated Single-Walled Carbon Nanotubes as a Versatile Platform with Radionuclide Labeling for Multimodal Tumor Imaging and Therapy.Recent advances of cocktail chemotherapy by combination drug delivery systems.Pluronic(®) P123/F127 mixed micelles delivering sorafenib and its combination with verteporfin in cancer cells.Stimuli-responsive hybrid nanocarriers developed by controllable integration of hyperbranched PEI with mesoporous silica nanoparticles for sustained intracellular siRNA delivery.Cationic Nanoparticles Assembled from Natural-Based Steroid Lipid for Improved Intracellular Transport of siRNA and pDNA.Alendronate-anchored PEGylation of ceria nanoparticles promotes human hepatoma cell proliferation via AKT/ERK signaling pathways.Gold Nanoparticle Approach to the Selective Delivery of Gene Silencing in Cancer-The Case for Combined Delivery?Targeting c-Met in Cancer by MicroRNAs: Potential Therapeutic Applications in Hepatocellular Carcinoma.Using biomaterials to rewire the process of wound repair.Targeted nanotechnologies for cancer intervention: a patent review (2010-2016).Multiple emulsions as effective platforms for controlled anti-cancer drug delivery.Selective anticancer activity of hydroxyapatite/chitosan-poly(d,l)-lactide-co-glycolide particles loaded with an androstane-based cancer inhibitor.Site-specific conjugation of single domain antibodies to liposomes enhances photosensitizer uptake and photodynamic therapy efficacy.Laminin Receptor-Avid Nanotherapeutic EGCg-AuNPs as a Potential Alternative Therapeutic Approach to Prevent Restenosis.Targeted brain delivery nanoparticles for malignant gliomas.Nanomedicines for renal disease: current status and future applicationsNanomedicine of synergistic drug combinations for cancer therapy - Strategies and perspectives.Dextran-coated superparamagnetic nanoparticles as potential cancer drug carriers in vivo.Paradigm shift in bacteriophage-mediated delivery of anticancer drugs: from targeted 'magic bullets' to self-navigated 'magic missiles'.Modular Assembly of Cell-targeting Devices Based on an Uncommon G-quadruplex Aptamer.Biomaterials in siRNA Delivery: A Comprehensive Review.Design of Organic Macrocycle-Modified Iron Oxide Nanoparticles for Drug Delivery.Nanoparticle delivery systems, general approaches, and their implementation in multiple myeloma.Leukocyte-mediated Delivery of Nanotherapeutics in Inflammatory and Tumor Sites.
P2860
Q26795601-45BB012E-D8DA-4E05-B109-CC7B7C6E68C6Q28078448-A86825DF-37A8-481C-9B4A-40D2421ED530Q28085280-5E1E7BD0-BB55-4ABA-B5A4-5870F4F5B0CBQ28385366-B245F532-2E2D-4C3C-A0B3-02A34478B9E9Q30101038-29766792-C0F7-4544-AC47-5C4A5D529829Q30357837-25C241F7-6B8B-4A1C-8D34-70DEB949BEE7Q30376531-3E634B5F-2114-479E-A5F3-7C6F69A024C0Q30379739-0232C587-BF5F-4E96-B7E6-DB9B4BE9B66DQ30818713-02FE2681-CD44-4B41-928E-8A0B84AC5F45Q36201940-C8C5ABAD-ED8D-40D8-9F21-9F3EB6E01CD5Q36296097-3C708367-50DE-49DC-8569-2E340DB45B97Q36651592-33771E10-F1E7-49F4-A620-C5B67A2EA0E1Q36701895-A0F98E9A-B82E-4DD4-A88C-B0840025D0FAQ36796334-FFEDB4F9-9093-4093-813A-A09ECF489294Q36951503-8EBD22EE-F1B1-4775-8D04-486B07354FA3Q37187697-AEE96C7E-2329-49E2-BB39-AB93842F6984Q37202299-A3022B9F-93AE-4DCE-8771-AD991FE2779CQ37206908-F426FFF8-57E2-47EB-9E53-6E8C50863149Q37248795-EF8492F3-6D53-4965-A8F5-3C8962C8F8DFQ37500100-B60C8A74-7BFF-4DD3-9359-A7485BB97806Q37636310-ECCAACBB-6175-436E-905D-D5E3CA44DE6CQ37648091-10C48E42-3D6E-4F63-8B76-E3562E72ED26Q37724113-6EDCEBFA-3756-4AD3-B651-61A1C9ABB846Q38585471-8ECB6233-9140-4506-8471-3B9ED0357140Q38660331-428081ED-9836-4511-9F04-EFA0550449B2Q38670236-6182F29E-EBA8-4A71-8668-CABC5EFBF52CQ38694627-3BBEDAAF-EB3C-4CED-9A5C-476A26C67110Q38733439-E28B1BCD-B574-42D4-B2AF-0D6C6BEFDE82Q38787937-E94EA00E-B0F2-48C7-B01D-B893B66C810FQ38789241-C114C48D-EE1B-4C29-83B5-C5B3A97B873CQ38791884-527F2949-318B-4E1D-A079-E7D7B8CA14B8Q38802375-C36A55CA-629C-4811-BD9D-D829D6ABE2B0Q38854876-85A1E0B5-39F9-4C94-9B66-A0B448623F5CQ38865350-2BF6B690-8E35-4E8F-B079-1F9B15B3182DQ38910806-A852D5CB-68F6-428B-AFD2-289B80E4B0C5Q38968703-5E1AD964-C973-4D5E-9782-70749271334CQ38971775-B2599543-4CCE-4CAC-A984-9D8B6B956E6DQ39121482-4EC9679D-12BC-43F2-8CA9-E9843D5303C0Q39139112-883A07CB-DA0D-4348-A41F-F929877A0679Q39159035-E717B7F5-E084-4379-BC07-2F73A13C5C03
P2860
Cancer nanomedicine: from targeted delivery to combination therapy
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Cancer nanomedicine: from targeted delivery to combination therapy
@ast
Cancer nanomedicine: from targeted delivery to combination therapy
@en
Cancer nanomedicine: from targeted delivery to combination therapy
@nl
type
label
Cancer nanomedicine: from targeted delivery to combination therapy
@ast
Cancer nanomedicine: from targeted delivery to combination therapy
@en
Cancer nanomedicine: from targeted delivery to combination therapy
@nl
prefLabel
Cancer nanomedicine: from targeted delivery to combination therapy
@ast
Cancer nanomedicine: from targeted delivery to combination therapy
@en
Cancer nanomedicine: from targeted delivery to combination therapy
@nl
P2093
P2860
P3181
P1476
Cancer nanomedicine: from targeted delivery to combination therapy
@en
P2093
William Ho
Xiaoyang Xu
Xueqing Zhang
P2860
P304
P3181
P356
10.1016/J.MOLMED.2015.01.001
P407
P5008
P577
2015-04-01T00:00:00Z